Bimatoprost FDA Link

A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Also Known As:

Lumigan; AGN 192024; Latisse; 192024, AGN; 5-Heptenamide, 7- (3,5- dihydroxy- 2- (3- hydrdoxy- 5- phenyl- 1- pentenyl)cyclopentyl)- N- ethyl- , (1R- (1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-

Organic Chemicals: 140
- Amides: 2487
  - Bimatoprost: 495
Lipids: 118169
- Fatty Acids: 28212
  - Unsaturated Fatty Acids: 8458
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Synthetic Prostaglandins: 835
        Synthetic Prostaglandins F: 2
        Cloprostenol: 60
        Bimatoprost: 495
Biological Factors: 2560
- Inflammation Mediators: 1126
  - Synthetic Prostaglandins: 835
    - Synthetic Prostaglandins F: 2
      - Cloprostenol: 60
        Bimatoprost: 495
  - Autacoids: 278
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Synthetic Prostaglandins: 835
        Synthetic Prostaglandins F: 2
        Cloprostenol: 60
        Bimatoprost: 495

Gurpreet S Ahluwalia Selected Research

Gurpreet S Ahluwalia Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure